Eulerpool Terminal
The edge that pays for itself.
Current Ryvu Therapeutics forecasts and price targets in August 2026
Ø Analyst Price Targets
54.50 PLN
+269.76 %
Median
32.64 PLN
+121.44 %
Max
104.27 PLN
Min
29.29 PLN
Last Price
14.74 PLN
Buy
6
Hold
2
Sell
0
The average target price for Ryvu Therapeutics is 54.50 PLN. (+269.76 % above the current price)
The median price target of Ryvu Therapeutics is 32.64 PLN.
Stock analysts from many renowned investment banks are closely examining the Ryvu Therapeutics stock. They conclude their professional Ryvu Therapeutics stock analyses with a clear recommendation for the Ryvu Therapeutics stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 6 | 2 | 0 | 54.50 PLN |
| 2026-01-01 | 6 | 2 | 0 | 54.50 PLN |
| 2025-12-01 | 6 | 2 | 0 | 54.50 PLN |
| 2025-12-01 | 6 | 2 | 0 | 60.62 PLN |
| 2025-11-01 | 6 | 2 | 0 | 57.71 PLN |
| 2025-11-01 | 6 | 2 | 0 | 57.71 PLN |
Ryvu Therapeutics Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Ryvu Therapeutics in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2025e | 84.00 M PLN | -107.00 M PLN | -4.63 PLN |
| 2026e | 110.00 M PLN | -50.00 M PLN | -2.16 PLN |
| 2027e | 106.00 M PLN | -2.00 M PLN | -0.09 PLN |